-
Tetracycline: Workflows, Selection, and Assay Design
2026-08-14
Tetracycline combines broad-spectrum antibacterial activity with practical value as an antibiotic selection marker and ribosomal function research tool. This guide connects disciplined bacterial workflows with assay-design lessons from recent HBV and ER-stress research, while emphasizing controls, storage, and troubleshooting.
-
EPZ5676: Practical DOT1L Inhibitor Workflows
2026-08-14
EPZ5676 combines picomolar DOT1L-binding potency with exceptional methyltransferase selectivity, making it a strong tool for connecting H3K79 methylation inhibition to leukemia-cell phenotypes. This workflow-oriented guide covers biochemical testing, MLL-rearranged models, orthogonal mechanism assays, and troubleshooting for reproducible results.
-
Sodium Orthovanadate: PTP Inhibition Guide
2026-08-13
Sodium Orthovanadate (Na3VO4) is a reversible, competitive inhibitor used to preserve tyrosine phosphorylation in cell lysates and protein tyrosine kinase assays. The A8524 product is a 98% research-grade solid with defined water solubility, solvent limitations, and cold-storage requirements.
-
L1023 Anti-Cancer Compound Library: STING Screening
2026-08-13
The L1023 Anti-Cancer Compound Library enables mechanism-aware cancer research across kinase, proteasome, epigenetic, and apoptosis pathways. This article explains how recent cryo-EM insights into STING activation can improve assay design, hit interpretation, and orthogonal validation.
-
(-)-Arctigenin as a Pathway-Dissection Tool
2026-08-12
(-)-Arctigenin offers a practical way to interrogate iNOS, NF-κB, and MEK1 signaling in inflammation-focused cancer models. This article connects its biochemical activities with macrophage EV–miR-660 biology while emphasizing assay controls, interpretation limits, and translational relevance.
-
Acetoacetic Acid Sodium Salt: Assay Design
2026-08-12
Acetoacetic acid sodium salt is more than a ketone-body reagent: its ionic chemistry and metabolic context determine how it should be used in energy metabolism research. This guide translates isotope-synthesis quality principles into practical assay decisions for diabetes and fatty acid catabolism studies.
-
Salmonella Haem, Phagocytosis, and Virulence
2026-08-11
A recent Nature Microbiology study identifies bacterial haem as an active regulator of Salmonella Typhimurium immune evasion rather than merely an iron-containing metabolic product. The work connects SirM-mediated HemL methylation to increased haem synthesis, TLR4-dependent suppression of macrophage Cdc42 activation, reduced phagocytosis, macrophage death, and enhanced virulence in mice.
-
FH1 for Mature iPS-Derived Hepatocytes
2026-08-11
FH1 is a practical chemical lever for improving albumin secretion, CYP3A4 expression, morphology, and AFP profiles in iPS-derived hepatocyte cultures. This guide combines FH1 workflow design with a carefully bounded translation of light-controlled gene regulation concepts for more informative liver-model assays.
-
Alfuzosin HCl Workflows for BPH Research
2026-08-10
Build reproducible Alfuzosin HCl workflows for lower urinary tract physiology, formulation testing, and spectrophotometric quantification. The guide translates a validated binary-mixture assay into practical experimental decisions while addressing solubility, matrix interference, and functional-readout variability.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-09
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris can invade insect cells and proliferate intracellularly. Pharmacological pathway analysis identified clathrin-mediated endocytosis and macropinocytosis as major entry routes, while cytoskeletal perturbation implicated both microtubules and actin filaments in infection.
-
Green Spectrophotometry for Alfuzosin HCl and Tadalafil
2026-08-08
A 2024 BMC Chemistry study introduced absorbance subtraction and ratio-difference UV–visible spectrophotometric methods for simultaneously quantifying Alfuzosin HCl and tadalafil in fixed-dose tablets. The validated approaches address severe spectral overlap without chromatographic separation, offering a comparatively simple and affordable option for pharmaceutical assay workflows.
-
ABT-263 (Navitoclax) for Apoptosis Workflows
2026-08-07
ABT-263 (Navitoclax) provides a practical way to test how Bcl-2 family dependence shapes mitochondrial and caspase-dependent cell death. This workflow guide connects dose-response apoptosis assays with Pol II degradation research, resistant cancer models, and troubleshooting strategies for reproducible results.
-
FH1 Small Molecule: Enabling Mature Hepatocyte Function for
2026-08-07
Discover how the FH1 small molecule drives superior cultured hepatocyte function enhancement and iPS cell differentiation to mature liver cells. This article uniquely explores FH1's mechanistic impact on translational workflows and bridges optogenetic gene control with functional liver model optimization.
-
Vitamin C (CAS 50-81-7): Reliable Solutions for Cell-Based A
2026-08-06
This article provides scenario-driven guidance for integrating high-purity Vitamin C (CAS 50-81-7), SKU B2064, into cell viability, proliferation, and senescence assays. Drawing from protocol-level data, peer-reviewed evidence, and product dossier details, it demonstrates how APExBIO's reagent supports reproducible, sensitive, and efficient workflows for cancer and aging research.
-
Green Spectrophotometric Quantification of Alfuzosin HCl–Tad
2026-08-06
Alqahtani et al. introduce the first green spectrophotometric methods enabling accurate quantification of alfuzosin hydrochloride and tadalafil in fixed-dose combination tablets. Their mathematical approach overcomes spectral overlap, providing a more accessible and eco-friendly alternative to chromatographic analysis in benign prostatic hyperplasia research.